CME Group Inc. (NASDAQ:CME) CEO Phupinder Gill sold 30,002 shares of the stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $110.00, for a total value of $3,300,220.00. Following the sale, the chief executive officer now owns 116,222 shares of the company’s stock, valued at approximately $12,784,420. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Phupinder Gill also recently made the following trade(s):

  • On Monday, August 15th, Phupinder Gill sold 20,080 shares of CME Group stock. The shares were sold at an average price of $104.54, for a total value of $2,099,163.20.
  • On Tuesday, June 28th, Phupinder Gill sold 31,120 shares of CME Group stock. The shares were sold at an average price of $93.14, for a total value of $2,898,516.80.

Shares of CME Group Inc. (NASDAQ:CME) opened at 108.91 on Thursday. The stock has a 50 day moving average price of $106.40 and a 200 day moving average price of $98.59. CME Group Inc. has a 1-year low of $81.87 and a 1-year high of $110.35. The firm has a market capitalization of $36.90 billion, a PE ratio of 27.50 and a beta of 0.85.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/phupinder-gill-sells-30002-shares-of-cme-group-inc-cme-stock.html

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The company earned $906 million during the quarter, compared to analysts’ expectations of $897.84 million. During the same quarter in the previous year, the company posted $0.95 earnings per share. The business’s revenue was up 10.5% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post $4.44 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 26th. Stockholders of record on Friday, September 9th will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date is Wednesday, September 7th. CME Group’s dividend payout ratio is presently 60.61%.

A number of analysts have commented on the company. JPMorgan Chase & Co. set a $116.00 price objective on CME Group and gave the stock a “buy” rating in a research report on Monday, September 12th. Jefferies Group raised their price objective on CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a research report on Wednesday, August 31st. Zacks Investment Research downgraded CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 7th. Deutsche Bank AG raised their price objective on CME Group from $111.00 to $112.00 and gave the stock a “buy” rating in a research report on Friday, August 5th. Finally, Keefe, Bruyette & Woods raised their price objective on CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a research report on Friday, July 29th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $102.89.

Several large investors have recently modified their holdings of the company. Tower Research Capital LLC TRC boosted its stake in shares of CME Group by 447.6% in the second quarter. Tower Research Capital LLC TRC now owns 1,621 shares of the company’s stock worth $157,000 after buying an additional 1,325 shares in the last quarter. Parametrica Management Ltd purchased a new stake in shares of CME Group during the second quarter worth about $212,000. Private Advisor Group LLC purchased a new stake in shares of CME Group during the second quarter worth about $214,000. Ranger International Management LP bought a new stake in shares of CME Group during the second quarter valued at about $219,000. Finally, Evercore Wealth Management LLC boosted its stake in shares of CME Group by 19.5% in the second quarter. Evercore Wealth Management LLC now owns 2,270 shares of the company’s stock valued at $221,000 after buying an additional 370 shares during the period. Institutional investors own 80.29% of the company’s stock.

CME Group Company Profile

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.